Ligand Pharmaceuticals Insider Sold Shares Worth $1,566,094, According to a Recent SEC Filing

04:52 PM EST, 11/04/2026 (MT Newswires) -- Andrew Reardon, Chief Legal Officer & Secretary, on November 02, 2026, sold 5,000 shares in Ligand Pharmaceuticals (LGND) for $1,566,094. Following the Form 4 filing with the SEC, Reardon has control over a total of 31,854 common shares of the company, with 31,854 shares held directly. Sales were made pursuant to a written trading plan adopted on June 4, in accordance with Rule 10b5-1. SEC Filing: https://www.sec.gov/Archives/edgar/data/886163/000195023226000006/xslF345X05/wk-form4_1793827374.xml